Gefitinib英文翻译_含义_读音_Gefitinib例句_月亮词典

Gefitinib

吉非替尼

常用释义

词性释义

易瑞沙

吉非替尼

例句

全部
吉非替尼

Gefitinib failed to show superiority to placebo as second- or third-line treatment, but it has been shown to be non inferior to docetaxel.

吉非替尼在二线和三线治疗中与安慰剂相比无优势，但其作用不逊于多西他赛。

However, this specific mutation did not cause acne, another side of effect of gefitinib.

然而，这种特异性的突变不会导致gefitinib的另一个副作用：痤疮。

Gefitinib may have inhibitory effects against bone resorption as well as antitumor effects.

吉非替尼可能会抑制对骨吸收以及抗肿瘤作用。

Being female was also significantly associated with response to gefitinib.

病人是女性也与对吉非替尼有反应显著相关。

The acute toxicity of gefitinib up to 500 mg in clinical studies has been low.

急性毒性吉非替尼多达500毫克的临床研究一直很低。

Doctor, the profile that you just read is actually for (gefitinib) IRESSA.

医生，刚才您所阅读的简介其实就是（吉非替尼）易瑞沙。

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

肺癌中表皮生长因子受体突变：吉非替尼治疗的临床反应。

What are your first thoughts about the potential indication for IRESSA (gefitinib) IRESSA? Do you agree ? Do you think it is appropriate?

对于易瑞沙（吉非替尼）的潜在迹象有什么想法？您是否赞同？您认为它是否合适？

The advantages that Gefitinib treated non-small cell lung cancer and the existing problems were expounded in this thesis.

本文针对吉非替尼靶向治疗非肺癌小细胞肺癌中的优点和所面临的问题进行阐述。

We reported cases of non-small-cell lung cancer who had dramatic improvements of pathologic fractures with gefitinib.

我们报告的非小细胞肺癌有显着改善谁的病理性骨折与吉非替尼。

Results 31 patients with Gefitinib associated skin rash were divided Wind-Heat type, Damp-Heat type, Blood-Heat type and Blood-XU type.

结果31例吉非替尼相关皮疹患者，辨证分型为：风热型、湿热型、血热型、阴虚型；

Therefore, it would also provide necessary evidence to test EGFR mutations for the use of Gefitinib in CRCs.

因此，检测大肠癌EGFR外显子突变也为将吉非替尼疗应用于大肠癌提供理论依据。

A phase II study evaluated gefitinib and docetaxel as second-line therapy .

一项II期临床试验对gefitinib和多西他赛作为二线治疗方案进行检验。

Clinical observation on advanced stage adenocarcinoma of lung treated with gefitinib after failure of chemotherapy

吉非替尼治疗化疗失败晚期肺腺癌的临床观察

Gefitinib in patients with advanced refractory small cell lung cancer contemporaneous with superior vena cava syndrome

吉非替尼治疗晚期难治性小细胞肺癌合并急性上腔静脉综合征

Efficacy of Gefitinib on Chinese Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer: a Clinical Trial

吉非替尼治疗局部晚期或转移性非小细胞肺癌在中国的临床研究

Overview of relationship between EGFR gene mutation and efficacy and acquired drug resistance of gefitinib

EGFR基因突变与吉非替尼的疗效和获得性耐药关系的研究概况

Effect of EGFR inhibitor gefitinib on proliferation and apoptosis of hepatocellular carcinoma cells

EGFR抑制剂吉非替尼对肝癌细胞增殖和凋亡的影响

Preliminary observation of gefitinib in salvage treatment of patients with previouslytreated, advanced non-small cell lung cancer

吉非替尼挽救性治疗晚期非小细胞肺癌的初步观察

Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor

表皮生长因子受体酪氨酸激酶抑制剂吉非替尼

1·Doctor, the profile that you just read is actually for (gefitinib) IRESSA.

医生，刚才您所阅读的简介其实就是(吉非替尼)易瑞沙。

2·Fortuitously, these drugs also have clinically obvious pharmacodynamic end points-hypertension for bevacizumab and skin toxicity for erlotinib and gefitinib.

例外的是，这些药物也有临床明显的药物副作用——贝伐单抗可致高血压，吉非替尼和厄洛替尼可有皮肤毒性。

3·Background: Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer.

背景：此前的无对照研究显示肺癌一线治疗联合吉非替尼治疗非小细胞肺癌是有效的。

4·Objective: To synthesize gefitinib.

前言：目的：合成吉非替尼。